Skip to main content

Susana Gómez Olles

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Susana Gómez Olles

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

BIOMARCADORES NO INVASIVOS DE DISFUNCIÓN CRÓNICA EN TRASPLANTE PULMONAR.

IP: -
Collaborators: Carles Bravo Masgoret, Meritxell Boada Perez, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI22/01103
Duration: 01/01/2023 - 31/12/2025

Grup de Recerca en Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Sergi Martí Beltran, Marta Vicenta Arjona Perís, Christian Eduardo Romero Mesones, Maria Angeles Jiménez Fuentes, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Álvarez Fernandez, Victor Monforte Torres, Odile Romero Santo-Tomas, Miriam Barrecheguren Fernández, David Clofent Alarcón, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Almudena Felipe Montiel, Gerard Orriols Torras, Victoria Ruiz De Miguel, Meritxell Boada Perez, David Espejo Castellanos, Manuel López Meseguer, David Soler Segovia, Susana Gómez Olles, Cristina Esquinas López, Berta Saez Gimenez, Grup de Recerca en Pneumologia, Iñigo Ojanguren Arranz, Eva Polverino , Alexa Gabriela Nuñez Dubon, Letizia Traversi
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 0.01
Reference: 2021 SGR 00788
Duration: 01/01/2022 - 31/12/2024

Functional Immune-Monitoring of Virus-specific T and B-cell Responses in Solid Organ Transplant. Recipients receiving SARS-CoV-2 Vaccination (MoniToR)

IP: Susana Gómez Olles
Collaborators: -
Funding agency: Fundació La Marató de TV3
Funding: 195790.4
Reference: 1059/U/2021
Duration: 20/10/2021 - 20/10/2023

Partida para intensificació durant la 2a i 3a anualitat

IP: Susana Gómez Olles
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 60000
Reference: PI18/00035_INT_BERASTEGUI
Duration: 01/01/2020 - 30/06/2023

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Thaïs Murciano Carrillo

Thaïs Murciano Carrillo

Childhood Cancer and Blood Disorders
Read more
Albert Igual Barceló

Albert Igual Barceló

Senior researcher
Read more
Juan Ignacio Esteban Mur

Juan Ignacio Esteban Mur

Main researcher
Liver Diseases
Read more
Angel Manuel Lorente Cobo

Angel Manuel Lorente Cobo

Auxiliar Tècnic/a Recerca
Experimental Surgery Unit (ESU)
Preclinical Core Facilities
Core Facilities Area
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.